Scholars@Duke

• Research
• 

  Selected Grants

  • Mechanism-based targeting of unique survival signaling in residual tumors awarded by National Institutes of Health 2022 - 2027
  • Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies awarded by National Institutes of Health 2022 - 2027
  • Exploiting targeted therapy-induced ATM dependence in residual lung tumors awarded by Department of Defense 2021 - 2023
  • Selectively targeting apoptosis in PIK3CA mutant colorectal cancers awarded by National Institutes of Health 2016 - 2022

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.